Is a patient with 4 mm disc bulges at L3‑5 and L5‑S1 causing mild anterior thecal‑sac effacement, who underwent bilateral facet ablation 12 days ago, still a suitable candidate for sacrocolpopexy?

Sacrocolpopexy Candidacy After Recent Facet Ablation with Disc Bulges

This patient remains an appropriate candidate for sacrocolpopexy despite the recent bilateral facet ablation and mild disc bulges at L3-5 and L5-S1. The disc pathology described (4mm bulges with mild anterior thecal sac effacement) represents relatively minor degenerative changes that do not constitute contraindications to pelvic reconstructive surgery, and the 12-day interval since facet ablation is adequate for proceeding with the planned procedure.

Key Clinical Reasoning

Disc Pathology Assessment

The 4mm disc bulges at L3-5 and L5-S1 with mild thecal sac effacement represent minor degenerative findings that are extremely common in the general population. Research demonstrates that disc bulges have a 13% rate of spontaneous regression and are frequently asymptomatic 1. These findings do not predict poor surgical outcomes for non-spinal procedures and should not delay indicated pelvic surgery.

Critical distinction: The patient has disc bulges, not protrusions, extrusions, or sequestrations. Bulges represent the mildest form of disc pathology and are associated with minimal internal disc disruption 2. The mild thecal sac effacement without nerve root compression or cauda equina symptoms indicates this is not a surgical spine emergency.

Facet Ablation Timing

The 12-day interval since bilateral facet ablation is clinically sufficient for proceeding with sacrocolpopexy. Facet radiofrequency ablation is a minimally invasive outpatient procedure that does not compromise spinal stability or create contraindications to subsequent surgery 3, 4.

Important considerations:

• Facet ablation does not alter spinal anatomy or structural integrity
• The procedure targets pain-generating nerves, not load-bearing structures
• Post-ablation inflammation typically resolves within 7-10 days
• No evidence suggests increased surgical risk for non-spinal procedures after facet ablation

Sacrocolpopexy-Specific Factors

Sacrocolpopexy involves sacral promontory fixation, typically at S1-S2, which is anatomically distinct from the L3-5 and L5-S1 disc levels described 5. The surgical approach for sacrocolpopexy does not require manipulation of the lumbar spine or disc spaces where the patient's pathology exists.

Procedural considerations:

• Sacrocolpopexy uses anterior or laparoscopic approach to sacral promontory
• No posterior lumbar dissection required
• Positioning (lithotomy or supine) does not stress the affected disc levels
• The mesh attachment site (S1-S2) is below the pathologic disc levels

Clinical Decision Algorithm

Proceed with sacrocolpopexy if:

• Patient has no radicular symptoms (leg pain, weakness, numbness)
• No bowel/bladder dysfunction (cauda equina symptoms)
• Able to tolerate surgical positioning without severe pain
• Pain from facet ablation has stabilized or improved
• Pelvic organ prolapse symptoms warrant surgical intervention

Delay surgery only if:

• New-onset radiculopathy or neurological deficits develop
• Severe positional pain preventing supine positioning (red flag for critical stenosis) 6
• Acute worsening of back pain suggesting disc herniation progression
• Incomplete recovery from facet ablation with ongoing severe pain requiring opioids

Common Pitfalls to Avoid

Do not conflate spine pathology with surgical contraindications. Mild degenerative disc disease is present in the majority of adults over 40 and does not preclude non-spinal surgery. The evidence shows no correlation between facet pathology and outcomes of non-spine surgical procedures 4.

Do not delay indicated pelvic surgery for incidental spine findings. The disc bulges described are likely chronic, asymptomatic findings discovered during preoperative imaging. Unless causing active neurological compromise, they should not alter the surgical plan for pelvic organ prolapse.

Avoid unnecessary spine intervention. The evidence demonstrates that facet injections and ablations do not predict outcomes for lumbar fusion 4, and there is no indication these procedures should influence timing of unrelated pelvic surgery.

Perioperative Pain Management

Given the recent facet ablation and underlying spine pathology, implement multimodal analgesia for sacrocolpopexy 3:

• Preoperative: Continue current pain regimen; avoid opioid escalation
• Intraoperative: Regional anesthesia techniques when feasible
• Postoperative: Scheduled acetaminophen, NSAIDs (if not contraindicated), with opioids reserved for breakthrough pain only
• Positioning: Ensure neutral spine alignment during surgery to minimize stress on affected levels

The goal is aggressive pain control without opioid dependence, as spine surgery patients have 55% prevalence of chronic preoperative pain and are at higher risk for persistent postoperative opioid use 3.